National Oxygen Limited (BOM:507813)
India · Delayed Price · Currency is INR 57.28
-2.52 (-4.21%)
At close: Aug 21, 2026
National Oxygen Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 184.22 | 229.61 | 405.82 | 452.59 | 471.13 | 506.07 |
Other Revenue | 7.58 | 7.58 | - | - | - | -0 |
| 191.8 | 237.19 | 405.82 | 452.59 | 471.13 | 506.07 | |
Revenue Growth | -48.99% | -41.55% | -10.33% | -3.94% | -6.90% | 27.27% |
Cost of Revenue | 132.32 | 165.08 | 306.33 | 312.52 | 314.08 | 303.36 |
Gross Profit | 59.48 | 72.12 | 99.48 | 140.07 | 157.05 | 202.72 |
Selling, General & Admin | 27.15 | 29.48 | 35.08 | 35.08 | 37.19 | 38.96 |
Other Operating Expenses | 59.98 | 68.24 | 89.07 | 92.52 | 83.05 | 48.42 |
Operating Expenses | 109.64 | 120.85 | 156.36 | 160.94 | 152.91 | 118.32 |
Operating Income | -50.16 | -48.73 | -56.88 | -20.87 | 4.13 | 84.4 |
Interest Expense | -15.06 | -13.24 | -15.29 | -15.51 | -15.27 | -19.94 |
Interest & Investment Income | - | - | 2.33 | 1.98 | 1.5 | 1.18 |
Currency Exchange Gain (Loss) | - | - | - | 0.07 | 0.02 | 0.04 |
Other Non Operating Income (Expenses) | 1 | -0.89 | -0.55 | 1.42 | -0.68 | 0.56 |
EBT Excluding Unusual Items | -64.22 | -62.86 | -70.39 | -32.92 | -10.3 | 66.24 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -1 |
Gain (Loss) on Sale of Assets | - | - | 0.06 | 0.47 | - | 10.98 |
Other Unusual Items | 81.23 | 81.23 | 0.3 | 0.12 | 2.39 | 0.06 |
Pretax Income | 17.01 | 18.37 | -70.02 | -32.33 | -7.91 | 76.27 |
Net Income | 17.01 | 18.37 | -70.02 | -32.33 | -7.91 | 76.27 |
Net Income to Common | 17.01 | 18.37 | -70.02 | -32.33 | -7.91 | 76.27 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Change | 0.09% | - | 2.94% | 2.00% | - | - |
EPS (Basic) | 3.37 | 3.64 | -13.89 | -6.60 | -1.65 | 15.88 |
EPS (Diluted) | 3.37 | 3.64 | -13.89 | -6.60 | -1.65 | 15.88 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -57.08 | -3.74 | -29.41 | 13.71 | 106.45 |
Free Cash Flow Per Share | - | -11.32 | -0.74 | -6.00 | 2.86 | 22.17 |
Gross Margin | 31.01% | 30.40% | 24.51% | 30.95% | 33.33% | 40.06% |
Operating Margin | -26.15% | -20.55% | -14.02% | -4.61% | 0.88% | 16.68% |
Profit Margin | 8.87% | 7.74% | -17.26% | -7.14% | -1.68% | 15.07% |
Free Cash Flow Margin | - | -24.07% | -0.92% | -6.50% | 2.91% | 21.04% |
EBITDA | -30.04 | -26.49 | -26.16 | 10.97 | 35.31 | 114.88 |
EBITDA Margin | -15.66% | -11.17% | -6.45% | 2.43% | 7.50% | 22.70% |
D&A For EBITDA | 20.12 | 22.24 | 30.72 | 31.85 | 31.18 | 30.49 |
EBIT | -50.16 | -48.73 | -56.88 | -20.87 | 4.13 | 84.4 |
EBIT Margin | -26.15% | -20.55% | -14.02% | -4.61% | 0.88% | 16.68% |
Revenue as Reported | 193.68 | 237.19 | 408.6 | 457.57 | 477.01 | 520.46 |